Research Article

Gender and Vascular Complications in the JAK2 V617F-Positive Myeloproliferative Neoplasms

Table 2

Major and minor vascular events, by gender.

Women ( 𝑛 = 1 6 4 )Men ( 𝑛 = 1 0 6 )P value

Vascular event history, number (%)44 (27)19 (18)0.09
 ET8 (18)5 (26)
 PV31 (71)9 (47)0.06
 MF5 (11)5 (26)

Vascular events, number5124
Major Venous Events, number (%)25 (49)10 (42)0.57
DVT/PE 8 (15.7)5 (20.8)0.47
 ET10
 PV64
 MF11
Abdominal venous thrombosis16 (31.4)4 (16.7)0.26
 ET22
 PV101
 MF41
Sinus venous thrombosis1 (2)1 (4.2)0.61
 ET01
 PV10
 MF00
Major Arterial Events, number (%)11 (22)6 (25)0.77
Cardiac (ACS) 5 (9.8)5 (20.8)0.14
 ET31
 PV23
 MF01
Neurologic (CVA)6 (11.8)1 (4.2)0.31
 ET10
 PV51
 MF00
Minor events, number (%)15 (29)8 (33)0.73
TIA 8 (15.7)3 (12.5)0.81
 ET10
 PV71
 MF02
Peripheral arterial thrombosis3 (5.8)2 (8.3)0.6
 ET10
 PV11
 MF11
Microvascular disturbance4 (7.8)3 (12.5)0.42
 ET22
 PV21
 MF00